Proactive Investors - Run By Investors For Investors

LexaGene Holdings reports favorable beta test results on its infectious disease diagnostic in animals

LexaGene Holdings Inc (OTCQB: LXXGF)(CVE: LXG) CEO and Founder Dr Jack Regan tells Proactive Investors the biotech company has reported favorable beta test results from its infectious disease diagnostic analyzer in animals at the Massachusetts Veterinary Referral Hospital.

Dr. Regan says the company's test returns results are produced in about one hour versus three or more days.

View full LXG profile View Profile

Lexagene Holdings Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use